SERUM VISFATIN IS ELEVATED IN CHINESE WOMEN WITH POLYCYSTIC OVARY SYNDROME, BUT MIGHT NOT BE A RELIABLE PREDICTOR OF THEIR GLUCOSE INTOLERANCE

Both visfatin and polycystic ovary syndrome (PCOS) were previously reported to be in relation to abnormal glucose metabolism (AGM). The hypothesis was investigated in this paper that plasma visfatin level are elevated in Chinese women with PCOS, and could substitute oral glucose tolerance test (OGTT) as a simple predictor for their glucose intolerance. This cross-sectional study enrolled 119 women (91 newly diagnosed PCOS patients and 28 eumenorrheic age- and BMI- matched controls); anthropometric, hormonal, and metabolic parameters including serum visfatin were simultaneously measured in all participants. Plasma visfatin levels were compared between controls and PCOS subjects with various glucose metabolism status diagnosed by OGTT using 75 g of glucose. Pearson correlation coefficients were calculated to determine the correlations between various parameters. Receiver Operating Characteristic (ROC) analysis was performed to examine the diagnostic test performance of visfatin. Plasma visfatin levels were found to be significantly higher in our PCOS population compared to healthy controls (P<0.05). An increase in fasting visfatin concentrations with a worsening degree of glucose intolerance among PCOS patients was described. However, the difference did not reach statistical significance. In addition, visfatin was unexpectedly found to correlate with neither age, anthropometric, hormonal nor metabolic parameters. As a predictor for glucose intolerance to distinguish PCOS individuals with normal or abnormal glucose metabolism, visfatin was found to possess low potentially predictive ability according to ROC curve analysis. In conclusion, serum visfatin is significantly elevated in Chinese women with PCOS, but might not be a reliable predictor of their glucose intolerance.